Christopher H. Rasskeh

Hospital of the University of Pennsylvania

Papers

Total Citations

H-Index

About

Christopher H. Rasskeh is a leading head and neck surgical oncologist whose research focuses on the diagnosis and treatment of human papillomavirus (HPV)-associated oropharyngeal carcinoma and cancers of unknown primary (CUP). His major contributions center on the application of transoral robotic surgery (TORS) as both a diagnostic and therapeutic modality, helping to refine management algorithms for patients with head and neck squamous cell carcinoma of unknown primary. In his influential 2025 paper, “Outcomes of HPV+ Oropharyngeal Carcinoma of Unknown Primary Following Transoral Robotic Surgery,” Rasskeh provides critical long-term oncologic outcomes data for this rare and challenging patient population. This work has already garnered early citations, reflecting its immediate impact on clinical practice. By demonstrating the efficacy and safety of TORS in this setting, Rasskeh’s research helps reduce treatment morbidity while maintaining excellent oncologic control. His ongoing investigations continue to shape evidence-based guidelines, offering surgeons and oncologists clearer pathways for managing occult primary tumors. For students and researchers, Rasskeh’s work exemplifies how surgical innovation can address diagnostic uncertainty and improve patient outcomes in head and neck oncology.